Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Cost of Public Health Response and Outbreak Control With a Third Dose of Measles-Mumps-Rubella Vaccine During a University Mumps Outbreak—Iowa, 2015–2016
Filetype[PDF-195.92 KB]


Details:
  • Alternative Title:
    Open Forum Infect Dis
  • Personal Author:
  • Description:
    Background

    The United States is experiencing mumps outbreaks in settings with high 2-dose measles-mumps-rubella (MMR) vaccine coverage, mainly universities. The economic impact of mumps outbreaks on public health systems is largely unknown. During a 2015–2016 mumps outbreak at the University of Iowa, we estimated the cost of public health response that included a third dose of MMR vaccine.

    Methods

    Data on activities performed, personnel hours spent, MMR vaccine doses administered, miles traveled, hourly earnings, and unitary costs were collected using a customized data tool. These data were then used to calculate associated costs.

    Results

    Approximately 6300 hours of personnel time were required from state and local public health institutions and the university, including for vaccination and laboratory work. Among activities demanding time were case/contact investigation (36%), response planning/coordination (20%), and specimen testing and report preparation (13% each). A total of 4736 MMR doses were administered and 1920 miles traveled. The total cost was >$649 000, roughly equally distributed between standard outbreak control activities and third-dose MMR vaccination (55% and 45%, respectively).

    Conclusions

    Public health response to the mumps outbreak at the University of Iowa required important amounts of personnel time and other resources. Associated costs were sizable enough to affect other public health activities.

  • Subject:
  • Pubmed ID:
    30302350
  • Pubmed Central ID:
    PMC6171567
  • Document Type:
    Journal Article
  • Collection(s):
    CDC Public Access
  • Main Document Checksum:
No Related Documents.
You May Also Like:
  1. VFC Resolution Update: Measles, Mumps, Rubella, and Varicella Vaccines
    Personal Author:
    Santoli, Jeanne M.
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Immunization Services Division.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2017 October 25-26 : Atlanta, GA)
    Published Date:
    01/04/2018
    Series:
    ACIP meeting Mumps
    Description:
    Presentations October 2017 Day 1Publication date from document properties.mumps-05-santoli-508.pdf
    File Type:
    Filetype[PDF - 2.38 MB]
  2. Considerations for the Use of the 3rd Dose of MMR Vaccine For Persons at Increased Risk Because of a Mumps Outbreak and Proposed Recommendations
    Personal Author:
    Marin, Mona
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices. Mumps Work Group.. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases..
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2017 October 25-26 : Atlanta, GA)
    Published Date:
    01/04/2018
    Series:
    ACIP meeting Mumps
    Description:
    Presentations October 2017 Day 1Publication date from document properties.mumps-04-marin-508.pdf
    File Type:
    Filetype[PDF - 2.38 MB]
  3. Mumps Outbreaks at Four Universities — Indiana, 2016
    Personal Author:
    Golwalkar, Mugdha; Pope, Brian; Stauffer, Jill; Snively, Ali; Clemmons, Nakia;
    Published Date:
    Jul 27 2018
    Source:
    MMWR Morb Mortal Wkly Rep. 67(29):793-797.
    Description:
    From February to April 2016, the Indiana State Department of Health (ISDH) confirmed mumps outbreaks at four universities (three public and one private). All universities were located within 65 miles of Indianapolis; however, epidemiologic links amon...
    File Type:
    Filetype[PDF - 232.45 KB]
  4. Recommendation of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus–Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreak
    Personal Author:
    Marin, Mona; Marlow, Mariel; Moore, Kelly L.; Patel, Manisha;
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). United States. Advisory Committee on Immunization Practices..
    Published Date:
    Jan 12 2018
    Source:
    MMWR Morb Mortal Wkly Rep. 67(1):33-38.
    Description:
    A substantial increase in the number of mumps outbreaks and outbreak-associated cases has occurred in the United States since late 2015 (1,2). To address this public health problem, the Advisory Committee on Immunization Practices (ACIP) reviewed the...
    File Type:
    Filetype[PDF - 106.55 KB]
  5. Effectiveness of a Third Dose of MMR Vaccine for Mumps Outbreak Control
    Personal Author:
    Cardemil, Cristina V.; Dahl, Rebecca M.; James, Lisa; Wannemuehler, Kathleen; Gary, Howard E.; Shah, Minesh; Marin, Mona; Riley, Jacob; Feikin, Daniel R.; Patel, Manisha; Quinlisk, Patricia;
    Published Date:
    September 07 2017
    Source:
    N Engl J Med. 377(10):947-956
    Description:
    BACKGROUNDThe effect of a third dose of the measles-mumps-rubella (MMR) vaccine in stemming a mumps outbreak is unknown. During an outbreak among vaccinated students at the University of Iowa, health officials implemented a widespread MMR vaccine cam...
    File Type:
    Filetype[PDF - 379.15 KB]